CoreWeave Complaint Overview
The class action lawsuit asserts securities fraud claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in CoreWeave securities. The class action is pending in the U.S. District Court for the District of New Jersey. It is captioned Masaitis v. CoreWeave, Inc., No. 2:26-cv-00355.
If you lost money on your CoreWeave investment, you are encouraged to submit your information using the form on this page. You may also email adam@bfalaw.com or call 212.789.3619.
Why is CoreWeave Being Sued for Securities Fraud?
CoreWeave, Inc. has been sued for securities fraud following significant stock drops resulting from potential violations of the federal securities laws. The declines in CoreWeave’s stock price caused significant losses to investors.
CoreWeave is an AI-focused cloud computing company that builds and operates data centers offering high-performance GPU infrastructure. Customers rent this infrastructure to run AI models and other compute-intensive workloads. CoreWeave relies on multiple partners to develop its data centers and provide the infrastructure needed for its AI computing operations, including Core Scientific, a large digital infrastructure company.
During the relevant period, CoreWeave repeatedly assured investors it could capitalize on the “robust” and “unprecedented” demand for its services given its “competitive strengths,” including its ability to “deploy” AI infrastructure “at massive scale” and “rapidly scale our operations,” and repeatedly maintained and even increased its revenue guidance. Key to CoreWeave’s ability to meet customer demand was a proposed merger with Core Scientific announced on July 7, 2025, which CoreWeave said would “significantly enhance operating efficiency and de-risk our future expansion, solidifying our growth trajectory.”
As alleged, in truth, CoreWeave overstated its ability to meet customer demand and concealed significant construction delays at its data centers.
Why did CoreWeave’s Stock Drop?
On October 30, 2025, Core Scientific announced it did not receive enough shareholder votes to approve the merger with CoreWeave and, as a result, terminated the merger agreement.
This news caused the price of CoreWeave stock to drop $8.87 per share, or more than 6%, from $139.93 per share on October 29, 2025, to $131.06 per share on October 30, 2025.
Then, on November 10, 2025, CoreWeave lowered guidance for revenue, operating income, capital spending, and active power capacity for 2025 due to “temporary delays related to a third-party data center developer who is behind schedule.”
This news caused the price of CoreWeave stock to drop $17.22 per share, or more than 16%, from $105.61 per share on November 10, 2025, to $88.39 per share on November 11, 2025.
Finally, on December 15, 2025, The Wall Street Journal published an article titled, “CoreWeave’s Staggering Fall From Market Grace Highlights AI Bubble Fears,” which reported that the “completion date” for a “huge data-center cluster” in Denton, Texas to be leased by OpenAI, “has been pushed back several months,” and that the site builder, Core Scientific, had “flagged weather-related delays” in August 2025, and that “[t]here were additional delays” involving Core Scientific “caused by revisions to design plans . . . in Texas and elsewhere,” which “Core Scientific has been flagging . . . since at least February.”
This news caused the price of CoreWeave stock to drop $2.85 per share, or more than 3%, from $72.35 per share on December 15, 2025, to $69.50 per share on December 16, 2025.
CoreWeave (CRWV) Stock Chart
NASDAQ online chart showing the CoreWeave (CRWV) stock drops following the October, November, and December 2025 news.
What is the CoreWeave Leadership Deadline?
You may ask the Court no later than March 13, 2026, to appoint you as Lead Plaintiff through counsel of your choice.
To be a member of the Class, you need not take any action at this time. The ability to share in any potential future recovery is not dependent on serving as Lead Plaintiff.
How Do I Submit My Information?
If you lost money when CoreWeave securities dropped in price, you are encouraged to submit your information using the form on this page to speak with an attorney about your rights.
You can also contact:
Adam McCall
adam@bfalaw.com
212.789.3619
All representation is on a contingency fee basis; there is no cost to you. Shareholders are not responsible for any court costs or expenses of the class action lawsuit. The firm will seek court approval for any potential fees and expenses.
Why Bleichmar Fonti & Auld LLP?
BFA is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It has been named a top plaintiff law firm by Chambers USA, The Legal 500, and ISS SCAS.
BFA attorneys have been named “Elite Trial Lawyers” by the National Law Journal, among the top “500 Leading Plaintiff Financial Lawyers” by Lawdragon, “Titans of the Plaintiffs’ Bar” by Law360 and “SuperLawyers” by Thomson Reuters.
BFA’s notable successes include a recovery of over $900 million in value from Tesla, Inc.’s Board of Directors, as well as $420 million from Teva Pharmaceutical Ind. Ltd.
Attorney advertising. Past results do not guarantee future outcomes.
